Abrdn Healthcare Investors (HQH) Fair Value 2026

HQH · Asset Management ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.9 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-28, Abrdn Healthcare Investors (HQH) trades at $22.67, versus a $79.79 median fair value across its 2 active models — 252.0% above the current price. QOC: 4.9/10. Value Trap Risk: 0/100 (SAFE). 2/13 models active.

Key Facts

Ticker
HQH
Price
$22.67
Quality Score
4.9/10
Value Trap Risk
0/100
Models Active
2/13
Last Updated
Strength: Markov DDM suggests +381.9% upside with 12% confidence
Risk: Below-average Quality Score of 4.9/10 signals weak fundamentals

Is Abrdn Healthcare Investors (HQH) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Abrdn Healthcare Investors (HQH) appears undervalued as of : the median of 2 independent fair value estimates is $79.79, 252.0% above the current price of $22.67. Estimates range from $50.34 to $109.25. HQH scores 4.9/10 on fundamental quality and 0/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. HQH’s +252.0% gap is wider than that market norm, and the Asset Management sector median is -4.4%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Abrdn Healthcare Investors Stock in 2026? →

What Fair Value Does Each Model Give HQH?

2 Intrinsic Value Models vs. Current Price ($22.67)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · Low Conviction
 $109.25 +381.9%
Relative · Low Conviction
 $50.34 +122.1%

All Models Active

All 2 models are displayed above.

What Is Abrdn Healthcare Investors (HQH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Abrdn Healthcare Investors. Trading at $22.67 against an estimated intrinsic value of $79.79, 2 of 2 active models flag meaningful upside of +252.0% at the median. The most optimistic model, Markov DDM, places fair value at $109.25 (+381.9%), while Regime Cross — the most conservative — estimates $50.34 (+122.1%). This +259.8% gap reflects genuine analytical uncertainty about Abrdn Healthcare Investors's intrinsic worth.

What Do the Models Say About HQH?

2 of 13 models are currently active for HQH. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for HQH is $79.79 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does HQH Rank in Asset Management?

Among 187 Asset Management stocks, HQH ranks #121 by Quality of Company score. CirclFi's QOC score of 4.9/10 evaluates 32 fundamental signals. A score of 4.9 reflects mixed fundamentals.

See all Most Undervalued Asset Management Stocks →

Abrdn Healthcare Investors operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is HQH a Value Trap?

CirclFi's Value Trap algorithm assigns HQH a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Abrdn Healthcare Investors. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Abrdn Healthcare Investors's fundamental quality profile registers 4.9/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +259.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HQH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HQH's 2 active models, average confidence is 10%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Abrdn Healthcare Investors Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Asset Management Stocks Should You Also Analyze?

11 related Asset Management stocks with 13-model coverage

PIMFranklin Master Intermediate Income TrustQOC 4.9BOEBlackRock Enhanced Global Dividend TrustQOC 4.9BGRBlackRock Energy and Resources TrustQOC 4.9VVRInvesco Senior Income TrustQOC 4.8PPTFranklin Premier Income TrustQOC 4.9BLWBlackRock Limited Duration Income TrustQOC 4.8AMBRAmber International Holding LimitedQOC 2.5NTRSNorthern Trust CorporationQOC 7.6RWAYRunway Growth Finance Corp.QOC 6.1HLNEHamilton Lane IncorporatedQOC 9.3AMPAmeriprise Financial, Inc.QOC 9.3

Read investment analysis: PIM · BOE · BGR · VVR · PPT · BLW · AMBR · NTRS · RWAY · HLNE · AMP

Which Other Stocks Have a Similar Quality Score to HQH?

6 companies across all industries closest to HQH’s Quality of Company score of 4.9/10.

HYEXHealthy Extracts Inc.QOC 4.9FUSEFusemachines Inc.QOC 4.9GWAVGreenwave Technology Solutions, Inc.QOC 4.9MGAMMobile Global Esports Inc.QOC 4.9CRVSCorvus Pharmaceuticals, Inc.QOC 4.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: HYEX · FUSE · GWAV · MGAM · CRVS · NVDA

Where Does HQH Sit in CirclFi's Asset Management Rankings?

HQH is ranked against every other Asset Management stock CirclFi covers in each of these screens.

See all Asset Management stocks ranked →

What Else Do Investors Ask About Abrdn Healthcare Investors’s Valuation?

What is Abrdn Healthcare Investors's intrinsic value in 2026?

CirclFi puts Abrdn Healthcare Investors (HQH)'s intrinsic value at $79.79 — the median of 2 independent model estimates as of 2026-08-28, ranging from $50.34 to $109.25. The Quality of Company score is 4.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HQH overvalued or undervalued right now?

At $22.67, 2 of 2 active models suggest HQH may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $79.79, 252.0% above the current price of $22.67 — a consensus view that HQH is undervalued. The assessment depends on which methodology best fits Abrdn Healthcare Investors's business model in Asset Management.

What does a Quality of Company score of 4.9 mean for HQH?

Abrdn Healthcare Investors's QOC of 4.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on HQH?

CirclFi analyzes HQH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is HQH a value trap in 2026?

Abrdn Healthcare Investors's Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Abrdn Healthcare Investors (HQH) has a median fair value of $79.79 — 252.0% above the current price of $22.67 — as of 2026-08-28.” Source: circlfi.com/stock/HQH/ · Methodology
Primary sources for this HQH valuation
  • Financial statements: Abrdn Healthcare Investors 10-K and 10-Q filings on SEC EDGAR (CIK 0000805267) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for HQH as of ; valuations recomputed .